Beta<sub>2</sub>-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care. [PDF]
Skolnik N +9 more
europepmc +1 more source
Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Selection for Patients with Moderate-to-Severe Asthma: Considerations for Real-World Practice, A Narrative Review. [PDF]
Blakey JD +5 more
europepmc +1 more source
Patterns and Adherence to GOLD-Recommended Inhaled Therapy in Chronic Obstructive Pulmonary Disease (COPD) Patients with Acute Exacerbation History in Primary Care in China. [PDF]
Pei H +14 more
europepmc +1 more source
Single-Inhaler Triple Therapy (SITT) for COPD: An Italian expert opinion paper on improving clinical outcomes and equity of therapeutic access. [PDF]
Bianco A +6 more
europepmc +1 more source
The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometry. [PDF]
Cao J +12 more
europepmc +1 more source
Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside. [PDF]
Calzetta L +6 more
europepmc +1 more source
Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings. [PDF]
Han P, Wang L.
europepmc +1 more source
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study. [PDF]
Gessner C +23 more
europepmc +1 more source
A Pragmatic RCT of FF/UMEC/VI in Patients with Uncontrolled Asthma: PERFORM Protocol. [PDF]
Noorduyn SG +9 more
europepmc +1 more source
Worsened longitudinal visit-to-visit-FEV<sub>1</sub>-variation and mortality in WTC exposed FDNY workers: a 23-year landmark analysis. [PDF]
Walraedt MH +6 more
europepmc +1 more source

